Please login to the form below

Not currently logged in
Email:
Password:

INC Research promotes Susan Akers-Smith to senior oncology role

She takes up the position of VP of early phase oncology development

Contract research organisation (CRO) INC Research has promoted Susan Akers-Smith to VP of early phase oncology development.

She joined the CRO in 2004, holding a series of oncology-focused roles and serving most recently as executive director of clinical development in oncology.

Nicholas Kenny, executive VP and general manager, global oncology and haematology at INC Research, said: "We are thrilled to recognise Susan's individual efforts, creativity and performance through this well-deserved promotion.

"We always strive to combine operational efficiency with the latest advancements in medical and regulatory knowledge to conduct cancer trials of the highest quality. Susan epitomises the leadership traits necessary for this role and we look forward to leveraging her experience to further support the growing early phase oncology research needs of our customers."

Akers-Smith brings to her new role more than a decade of management experience in the CRO industry focused on early phase oncology development, with therapeutic experience including a broad range of study designs and tumour types.

Prior to working in the CRO industry, she worked in emergency healthcare and served in the US Army Reserve.

6th September 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics